MN

Michal Novak

AS Axon Neuroscience Se: 8 patents #2 of 8Top 25%
LS Lay Line Genomics S.P.A.: 2 patents #4 of 14Top 30%
📍 Bratislava, SK: #8 of 256 inventorsTop 4%
Overall (All Time): #439,322 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12404322 Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease Eva Kontseková, Branislav Kovacech, Norbert Zilka 2025-09-02
11319363 Humanized tau antibodies in Alzheimer's disease Eva Kontseková, Branislav Kovacech, Rostislav Skrabana 2022-05-03
11098106 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease Eva Kontseková, Branislav Kovacech, Norbert Zilka 2021-08-24
10745469 Humanized tau antibodies in alzheimer's disease Eva Kontseková, Branislav Kovacech, Rostislav Skrabana 2020-08-18
10160799 Humanized tau antibodies in a alzheimer's disease Eva Kontseková, Branislav Kovacech, Rostislav Skrabana 2018-12-25
9845352 Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease Eva Kontseková, Branislav Kováce{hacek over (c)}h, Norbert {hacek over (Z)}ilka 2017-12-19
9828421 Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease Eva Kontseková, Branislav Kováce{hacek over (c)}h, Norbert {hacek over (Z)}ilka 2017-11-28
9518101 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease Eva Kontseková, Branislav Kovacech, Norbert Zilka 2016-12-13
8486401 Monoclonal antibodies binding to TrkA and acting as NGF-antagonist molecules and their use for treating pain induced by NGF 2013-07-16
7601352 Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA 2009-10-13
7446180 Conformationally abnormal forms of tau proteins and specific antibodies thereto 2008-11-04